GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Beta

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Beta : N/A (As of May. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-24), Cryofocus Medtech (Shanghai) Co's Beta is Not available.


Cryofocus Medtech (Shanghai) Co Beta Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Beta Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Beta
- - - -

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Beta Get a 7-Day Free Trial - - - - -

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Beta

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryofocus Medtech (Shanghai) Co's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Beta distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Beta falls into.



Cryofocus Medtech (Shanghai) Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Cryofocus Medtech (Shanghai) Co  (HKSE:06922) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cryofocus Medtech (Shanghai) Co Beta Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.
Executives
Wu Jianhui 2101 Beneficial owner
Li Hui 2202 Interest of your spouse
Lv Shiwen 2103 Interests held jointly with another person
Sun Xiaolu 2201 Interest of corporation controlled by you
Zhang Qian
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi He Huo Qi Ye You Xian He Huo
Shang Hai Shi Di Sheng Wu Ke Ji You Xian Gong Si
Shang Hai Bi Lin Xing Zi Chan Guan Li You Xian Gong Si
Hang Zhou Bi Lin Xing Chuang Xin Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Ning Bo Lin Feng Sheng Wu Ke Ji You Xian Gong Si
Shang Hai Shi Di Shi Ye Fa Zhan You Xian Gong Si
Sheng Shan Zi Chan Guan Li Shang Hai You Xian Gong Si
Gan Shi Xiong
Su Zhou Gong Ye Yuan Qu Zhi Nuo Shang Wu Xin Xi Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Xin Jian Yuan Er Qi Chuang Ye Tou Zi Qi Ye You Xian He Huo 2101 Beneficial owner

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines